CIFoundry

Ophthalmology AI tools

Ophthalmology AI screens retinal images for diabetic retinopathy, macular degeneration and glaucoma. Some tools are cleared to make an autonomous diagnosis in primary care, without an eye specialist on site.

14
tools listed
6
FDA-cleared
3
with named health-system users
3
Epic-integrated

Well-documented ophthalmology tools

Not a ranking. Shown A–Z.

How we picked these

Tools are picked automatically from four public signals recorded in each listing: FDA clearance, De Novo or approval; health systems named as users in news reports; a linked published study; and Epic integration. A tool needs at least 2 of the 4 to appear. Tools with more signals, then more reported health-system users, come first, until about 8 are shown. Tools that tie are shown together or not at all (never more than 10), so no tool is picked over another by name. “Well-documented” describes the public record, not clinical quality. This list is based on information recorded in each listing; a tool's absence doesn't mean it lacks these qualities. No one can pay to appear here, and advertising never affects this list.

Evaluating a ophthalmology AI tool? Use our checklist

What physicians and administrators look for, evidence to ask for, how to test it locally, red flags and questions for the vendor.

All 14 ophthalmology AI tools

Listed A–Z. Listing is free, and no one can pay to change the order.

Ophthalmology
Research

DeepMind/Moorfields Retinal Disease AI (OCT diagnosis and referral)

Google DeepMind / Google Health, with Moorfields Eye Hospital and UCL Institute of Ophthalmology

This deep-learning system, developed by Google DeepMind (later Google Health) with Moorfields Eye Hospital and UCL, analyzes 3D optical coherence tomography (OCT) scans to diagnose and triage over 50 sight-threatening retinal conditions, including diabetic retinopathy and age-related macular degeneration. It uses a two-stage segmentation-and-classification architecture that provides interpretable visual explanations and matches expert clinician referral accuracy (>94%). It remains a research/validation-stage tool rather than a routine clinical product.

  • FDAnot on record
  • Epicnot on record
  • Named userson record
  • Studyon record
retinal image analysisOCTdiabetic retinopathy+5

Get weekly updates for Ophthalmology

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

How to evaluate ophthalmology AI

Regulatory status

Check whether the tool is FDA-cleared for the exact use you plan, or is a non-device or research tool. Every listing links to the FDA record where one exists.

Evidence

Look for peer-reviewed validation, ideally in patients and settings like yours, and ask vendors how performance is monitored after go-live.

Integration

Confirm how it fits your EHR and workflow (Epic, PACS, FHIR) and who does the integration work.

Peer adoption

See which health systems already use it and ask peers in the forum about real-world results.

Can't find the right fit? Browse builder firms that build custom ophthalmology AI, or compare tools side by side.

Other specialties